Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy [Phase 1, Phase 2]
Clinical trial evaluating oral 7HP349 (Alintegimod) in combination with ipilimumab, followed by nivolumab monotherapy, in patients with adva…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy [Phase 2]
A Phase 2 study is evaluating Ivonescimab for pleural mesothelioma that has progressed after prior immunotherapy and chemotherapy; the trial…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma [Phase 2]
This clinical trial update describes a Phase 2 study testing the addition of immunotherapy before surgery for patients with pleural mesothel…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma [NA]
This clinical trial update notes a study evaluating partial pleurectomy (surgery) for unresectable pleural mesothelioma and indicates the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) [Phase 2]
CHIMERA is a Phase 2 trial evaluating induction chemotherapy plus immunotherapy in patients with resectable epithelioid and biphasic pleural…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Clinical trial status update indicates that Tumor Treating Fields (TTFields) are being studied in general routine clinical care for patients…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Study of Sacituzumab Govitecan in People With Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating Sacituzumab Govitecan for mesothelioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma [Phase 2]
This update describes a Phase 2 clinical trial assessing the diagnostic accuracy and clinical value of FAPI PET imaging in pleural mesotheli…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pembrolizumab in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating pembrolizumab in malignant mesothelioma and related subtypes; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: A Study of MT027 in Patients with Pleural Malignant Tumors [Phase 1]
Phase 1 clinical trial evaluating MT027 in patients with pleural malignant tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Evaluation of Response by FLT PET in Mesothelioma [NA]
This clinical trial evaluates FLT PET imaging to assess treatment response in patients with pleural mesothelioma and is currently recruiting…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma [Phase 2]
Phase 2 study evaluating cadonilimab in combination with chemotherapy for recurrent or refractory pleural mesothelioma; the trial is not yet…
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) [Phase 2]
Phase 2 clinical trial update on Tremelimumab combined with the anti-PD-L1 antibody durvalumab (MEDI4736) for malignant mesothelioma, includ…